Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement.
about
Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life.Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial.Placebo effect in clinical trial design for irritable bowel syndromeThe effect of tegaserod on symptoms and quality of life in korean women with irritable bowel syndrome with constipationEvidence-based clinical practice guidelines for irritable bowel syndrome.A novel technique for bedside anorectal manometry in humans.Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.Adequate relief in a treatment trial with IBS patients: a prospective assessment.A randomized controlled trial of imipramine in patients with irritable bowel syndrome.Psychometric assessment of the IBS-D Daily Symptom Diary and Symptom Event LogMeasuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scalePsychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report.Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea.Review article: endpoints used in functional dyspepsia drug therapy trials.New treatments for IBS.Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.Linaclotide: promising IBS-C efficacy in an era of provisional study endpoints.Validating endpoints for therapeutic trials in fecal incontinenceEditorial: is adequate relief fatally flawed or adequate as an end point in irritable bowel syndrome?Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment.The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice.Gastrointestinal well-being in subjects reporting mild gastrointestinal discomfort: characteristics and properties of a global assessment measure.UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation
P2860
Q33354789-25823889-9C13-4239-BFD1-10B4A8D34B4AQ33455506-A7E53245-B0DD-48CB-9CD3-A39931B33110Q33488090-04C70644-5514-42D9-9518-EB7C3E6ABEADQ33586880-B02700B3-7EB2-4E70-8847-B7224F9CAB43Q33890463-DBE507CD-849E-4C8A-A83F-52A0F720D78DQ35513973-F1815E04-ED45-4CBA-86D4-4EBF1B287390Q36096062-64E1463C-6594-4BFB-A717-6561987CA570Q36166972-DDDDE327-6DC1-4C9D-92D3-2CB6A8A37C94Q37164063-E22C3826-8C27-494B-A626-016FD23B2623Q37253528-0F547D57-6874-488E-A5EF-C778687CE2EEQ37290311-0D55AC75-4456-4021-9BCE-FB216299E2D6Q37405205-BCC573E8-C26A-450E-B1F9-7A2D813F05B4Q37475265-21677E24-D8A4-49A5-B493-FC834531E61DQ37475280-5313B2EB-ADF5-43E0-8132-6BE1608B678DQ37694028-12831758-92AE-4781-9F72-0E155037A0F5Q37827564-EF8CEAC8-CF17-467F-8BF3-BD30A8E3CDFCQ38059436-F0077C1F-6C70-438E-A311-026A334D284DQ39221980-7734EC57-248B-43BE-9A22-8840AF781CD9Q39276611-4C014E71-3D8D-4566-996C-036A09912A9DQ39335358-A3945053-FBE2-4BC2-8A59-33917E8B291DQ41103071-D46605D4-0ED5-4105-88AE-698E7D77E8EFQ42408269-6010C2EA-6CCB-49CE-B656-1FAB727A28F5Q42408757-120CFBF1-AFDC-44B5-A5C9-4E559CC30AAAQ42738877-0BBB9AFC-4AA6-4F29-80CB-65A2DAD0FD17Q43347891-76B77EA2-F415-47DD-80EF-17E973DB0955Q48238295-95DEE5D6-C7EF-4229-82D6-3856EBF7A3EBQ48293657-90DFA2DD-6AF0-4707-8673-D9BD53675DBCQ57298241-E55239D9-0AC7-455F-9606-B11A1F8252ED
P2860
Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Reports of "satisfactory relie ...... y reflect symptom improvement.
@en
Reports of "satisfactory relie ...... y reflect symptom improvement.
@nl
type
label
Reports of "satisfactory relie ...... y reflect symptom improvement.
@en
Reports of "satisfactory relie ...... y reflect symptom improvement.
@nl
prefLabel
Reports of "satisfactory relie ...... y reflect symptom improvement.
@en
Reports of "satisfactory relie ...... y reflect symptom improvement.
@nl
P2093
P2860
P1476
Reports of "satisfactory relie ...... y reflect symptom improvement.
@en
P2093
Andrew D Feld
Marsha Turner
Michael VonKorff
Olafur S Palsson
Rona L Levy
William E Whitehead
P2860
P304
P356
10.1111/J.1572-0241.2006.00535.X
P407
P577
2006-05-01T00:00:00Z